Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

BB Adamant Global Biotech AA Klasse

Objective

At least two thirds of the subfund's assets are invested directly and indirectly in equity securities of the biotechnology sector. A total of no more than one third of the subfund's assets may be invested in instruments, which invest partly but not predominantly in the biotechnology sector.

This fund is not currently tracked by Citywire in Netherlands View performance globally

Registered For Sale In

  1. Switzerland